7HBD
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr12810 | Descriptor: | Heat shock protein HSP 90-alpha, N-(3-chlorophenyl)-2-cyanoacetamide | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBE
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr12771 | Descriptor: | 5-methyl-2-(trifluoromethyl)furan-3-carboxamide, Heat shock protein HSP 90-alpha | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.79 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBF
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr12938 | Descriptor: | Heat shock protein HSP 90-alpha, {3-[(pyridin-2-yl)oxy]phenyl}methanol | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.97 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBG
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr13237 | Descriptor: | Heat shock protein HSP 90-alpha, N-methyl-1-{4-[(pyridin-2-yl)oxy]phenyl}methanamine | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.69 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBH
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr13518 | Descriptor: | (5-tert-butylthiophen-2-yl)(pyrrolidin-1-yl)methanone, Heat shock protein HSP 90-alpha | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBJ
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr13498 | Descriptor: | 6-(4-chloro-3-methylphenoxy)pyridin-3-amine, Heat shock protein HSP 90-alpha | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (2.65 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBK
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr13232 | Descriptor: | 6-(2,3-dimethylphenoxy)pyridin-3-amine, Heat shock protein HSP 90-alpha | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (2.14 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBM
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr13278 | Descriptor: | Heat shock protein HSP 90-alpha, N-cycloheptyl-N'-(2-hydroxyethyl)thiourea | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (2.21 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBN
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr13145 | Descriptor: | Heat shock protein HSP 90-alpha, {2-[(oxan-4-yl)oxy]phenyl}methanol | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.99 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBO
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr13368 | Descriptor: | Heat shock protein HSP 90-alpha, N-[(1S,2S,4S)-bicyclo[2.2.1]hept-5-en-2-yl]-N'-butyl-N-methylurea | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (2.07 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBP
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr13188 | Descriptor: | Heat shock protein HSP 90-alpha, N-(3,4-difluorophenyl)cyclobutanecarboxamide | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.91 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBQ
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with FS-2731 | Descriptor: | 5-bromo-2-(1H-pyrazol-1-yl)pyrimidine, Heat shock protein HSP 90-alpha | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (2.73 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBR
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with AS-5576 | Descriptor: | 4-(4-fluorophenyl)-1H-pyrazole, Heat shock protein HSP 90-alpha | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.91 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBS
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with 10X-0806 | Descriptor: | (5P)-2-chloro-5-(1,3-oxazol-5-yl)pyridine, Heat shock protein HSP 90-alpha | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.38 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBT
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with PS-3621 | Descriptor: | Heat shock protein HSP 90-alpha, [3-(4-methylphenyl)-1H-pyrazol-1-yl]acetic acid | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.38 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBV
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with PS-4833 | Descriptor: | 7-methoxy-1H-pyrrolo[2,3-c]pyridine, Heat shock protein HSP 90-alpha | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.56 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBW
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with PS-4774 | Descriptor: | 3-bromo-1H-pyrazolo[3,4-c]pyridine, Heat shock protein HSP 90-alpha | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.91 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBX
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with AS-5591 | Descriptor: | (3-methyl-5-phenyl-1,2-oxazol-4-yl)methanol, Heat shock protein HSP 90-alpha | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (2.25 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBY
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with 9R-0342 | Descriptor: | Heat shock protein HSP 90-alpha, N-[(4-fluorophenyl)methyl]-1H-pyrrole-2-carboxamide | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.82 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HBZ
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with 6R-0009 | Descriptor: | (4R)-5-chloro-3-ethyl[1,2,4]triazolo[4,3-a]pyridine, Heat shock protein HSP 90-alpha | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.44 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HC0
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with 4W-0801 | Descriptor: | 3-(3-bromothiophen-2-yl)-1H-pyrazole, Heat shock protein HSP 90-alpha | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.66 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HC1
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with 10T-0263 | Descriptor: | (3M)-3-(3-fluoro-4-methoxyphenyl)-4-methyl-1H-pyrazole, Heat shock protein HSP 90-alpha | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (2.13 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HC2
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with 2X-5009 | Descriptor: | Heat shock protein HSP 90-alpha, N-(pyridin-4-yl)cyclopropanecarboxamide | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (1.6 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HC3
 
 | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with 3T-0629 | Descriptor: | 2,3-dimethylpyrido[2,3-b]pyrazine, Heat shock protein HSP 90-alpha | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | Deposit date: | 2024-07-10 | Release date: | 2025-03-26 | Method: | X-RAY DIFFRACTION (2.22 Å) | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening. Iucrj, 12, 2025
|
|
7HCB
 
 | |